Insmed (INSM) Rose Following Drug Approval
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Insmed Inc (INSM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Darwin Global Management Abhishek Trehan | 20,457,445 | $2,897,797,084 | +6% | 80.54% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 6,703,484 | $965,368,731 | -14% | 6.98% |
| 3. | D E Shaw D. E. Shaw | 5,657,464 | $814,731,390 | +66% | 0.46% |
| 4. | Orbis Investment Management William B. Gray | 3,250,868 | $468,157,501 | +114% | 2.01% |
| 5. | Millennium Management Israel Englander | 2,336,112 | $336,423,489 | +11% | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.35 | 1,130 | $74,975.50 | 3,025 | 2025-05-21 | Filing | |
| $66.87 | 1,895 | $126,718.65 | 1,895 | 2025-05-20 | Filing | |
| $19.29 | 10,000 | $192,900.00 | 10,000 | 2023-05-15 | Filing | |
| $19.29 | 10,000 | $192,900.00 | 298,615 | 2023-05-15 | Filing | |
| $17.70 | 10,000 | $177,000.00 | 15,900 | 2022-11-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $207.73 | 1,559 | $323,851.07 | 83,111 | 2025-12-01 | Filing | |
| $207.03 | 5,886 | $1,218,578.58 | 84,670 | 2025-12-01 | Filing | |
| $205.98 | 1,450 | $298,671.00 | 90,556 | 2025-12-01 | Filing | |
| $204.58 | 5,000 | $1,022,900.00 | 58,729 | 2025-11-24 | Filing | |
| $197.40 | 15,174 | $2,995,347.60 | 54,677 | 2025-11-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,047,676 | $3,319,096,045 | 0.19% | |
| 2. | 19,935,820 | $2,870,957,439 | 0.04% | |
| 3. | 12,364,904 | $1,780,669,886 | 0.03% | |
| 4. | 9,180,963 | $1,322,150,532 | 0.07% | |
| 5. | 7,553,853 | $1,087,830,371 | 0.18% |
News See All
Here’s What Lifted Insmed Incorporated (INSM) in Q3
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Insmed Incorporated (NASDAQ:INSM) Q3 2025 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kayla, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Insmed Third Quarter 2025 Financial Results.
Insmed (INSM) Hits All-Time High as Firm Posts Highly Optimistic Outlook
Insmed rallied for a fourth straight day to reach a new all-time high, as investors took heart from a highly optimistic business outlook for the full-year period, despite widening its net loss in the ...
Does Insmed Incorporated (INSM) Have a Promising Pipeline?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Ohio Retirement Fund Invests in Insmed Incorporated (INSM)
Insmed Incorporated (NASDAQ:INSM) is among the most promising biotech stocks to buy according to hedge funds.
7 Most Promising Biotech Stocks to Buy According to Hedge Funds
If there’s one sector that is gaining popularity each day, it’s definitely the biotechnology market.
Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9%
Insmed Incorporated (NASDAQ:INSM) tops our list for being one of the best performing stocks.
12 Best Performing Healthcare Stocks to Buy Right Now
Spending on healthcare in the US is predicted to hit $5.3 trillion this year, making it one of the largest in the world.
Hedge Fund Resource Center Billionaire Hedge Funds
